We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$525M
AUM Growth
+$163M
Cap. Flow
-$365M
Cap. Flow %
-69.47%
Top 10 Hldgs %
34.54%
Holding
251
New
–
Increased
–
Reduced
–
Closed
140

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$17.3M
2
GIS icon
General Mills
GIS
+$16.1M
3
HGV icon
Hilton Grand Vacations
HGV
+$13.9M
4
D icon
Dominion Energy
D
+$13.5M
5
ACGL icon
Arch Capital
ACGL
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 20.2%
2 Financials 16.74%
3 Technology 15.78%
4 Industrials 10.99%
5 Energy 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRDN icon
201
Viridian Therapeutics
VRDN
$2.67B
– –
-6,267
Closed -$659K
VSTM icon
202
Verastem
VSTM
$610M
– –
-22,917
Closed -$820K
WHD icon
203
Cactus
WHD
$5.44B
– –
-435,000
Closed -$11.7M
WYNN icon
204
Wynn Resorts
WYNN
$10.6B
– –
-40,000
Closed -$7.29M
XNCR icon
205
Xencor
XNCR
$1.55B
– –
-240,000
Closed -$7.2M
XXII
206
22nd Century Group
XXII
$1.48M
– –
0
– -$164K
ZS icon
207
Zscaler
ZS
$27.3B
– –
-15,000
Closed -$24K
QTTB icon
208
Q32 Bio
QTTB
$464M
– –
-2,500
Closed -$842K
SEI
209
Solaris Energy Infrastructure
SEI
$3.82B
– –
-150,000
Closed -$2.48M
CDMO
210
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-16,618
Closed -$49K
GTHX
211
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-68,000
Closed -$2.52M
ASXC
212
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-2,317
Closed -$51K
AIU
213
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
– –
-360
Closed -$484K
NVTA
214
DELISTED
Invitae Corporation
NVTA
– –
-415,000
Closed -$1.95M
LHC.U
215
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
– –
-150,000
Closed -$1.5M
BKI
216
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-175,000
Closed -$8.24M
AQUA
217
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
– –
-340,000
Closed -$7.24M
VNTR
218
DELISTED
Venator Materials PLC
VNTR
– –
-430,000
Closed -$7.78M
COUP
219
DELISTED
Coupa Software Incorporated
COUP
– –
-40,000
Closed -$1.82M
GBT
220
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-100,000
Closed -$4.83M
CTT
221
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
– –
-80,000
Closed -$94K
XELA
222
DELISTED
Exela Technologies, Inc. Common Stock
XELA
– –
-2
Closed -$154K
SRRA
223
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-3,625
Closed -$300K
ZSAN
224
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-12,857
Closed -$2.27M
DISCK
225
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-150,000
Closed -$2.93M
6 7 8
9
10

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Monashee Investment Management held 251 positions worth $525M, up 45% from $362M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Monashee Investment Management withdrew a net $365M in Q2 2018, closing 140 positions. Its most notable exit was Sage Therapeutics, an estimated $17.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Monashee Investment Management fully exited Sage Therapeutics in Q2 2018, selling an estimated $17.3M.
  • Monashee Investment Management's ten largest holdings make up 35% of its $525M portfolio in Q2 2018.
  • Monashee Investment Management opened 0 new positions and closed 140 in Q2 2018.
  • Monashee Investment Management's portfolio value rose 45% quarter-over-quarter to $525M.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.